(Q113890491)

English

Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19 (English)
0 references
0 references
0 references
4 September 2020
0 references
15 February 2021
0 references
45
0 references
18 year
0 references
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit